Xenocoumacin 2 reduces protein biosynthesis and inhibits inflammatory and angiogenesis-related processes in endothelial cells

Publication date: August 2021Source: Biomedicine & Pharmacotherapy, Volume 140Author(s): Pelin Erkoc, Michaela Schmitt, Rebecca Ingelfinger, Iris Bischoff-Kont, Larissa Kopp, Helge B. Bode, Susanne Schiffmann, Robert Fürst
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research